UBS AM’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $653M | Buy |
|
|||||
2025
Q1 | $556M | Sell |
|
|||||
2024
Q4 | $573M | Buy |
|
|||||
2024
Q3 | $588M | Sell |
|
|||||
2024
Q2 | $585M | Buy |
|
|||||
2024
Q1 | $400M | Sell |
|
|||||
2023
Q4 | $394M | Buy |
|
|||||
2023
Q3 | $329M | Sell |
|
|||||
2023
Q2 | $411M | Hold |
|
|||||
2023
Q1 | $411M | Buy |
|
|||||
2022
Q4 | $403M | Sell |
|
|||||
2022
Q3 | $371M | Sell |
|
|||||
2022
Q2 | $437M | Buy |
|
|||||
2022
Q1 | $414M | Buy |
|
|||||
2021
Q4 | $438M | Buy |
|
|||||
2021
Q3 | $358M | Buy |
|
|||||
2021
Q2 | $373M | Buy |
|
|||||
2021
Q1 | $353M | Sell |
|
|||||
2020
Q4 | $389M | Buy |
|
|||||
2020
Q3 | $312M | Buy |
|
|||||
2020
Q2 | $290M | Sell |
|
|||||
2020
Q1 | $267M | Buy |
|
|||||
2019
Q4 | $254M | Buy |
|
|||||
2019
Q3 | $252M | Sell |
|
|||||
2019
Q2 | $249M | Sell |
|
|||||
2019
Q1 | $243M | Buy |
|
|||||
2018
Q4 | $197M | Buy |
|
|||||
2018
Q3 | $214M | Buy |
|
|||||
2018
Q2 | $205M | Sell |
|
|||||
2018
Q1 | $255M | Buy |
|
|||||
2017
Q4 | $263M | Buy |
|
|||||
2017
Q3 | $181M | Sell |
|
|||||
2017
Q2 | $186M | Sell |
|
|||||
2017
Q1 | $185M | Buy |
|
|||||
2016
Q4 | $149M | Sell |
|
|||||
2016
Q3 | $208M | Sell |
|
|||||
2016
Q2 | $212M | Sell |
|
|||||
2016
Q1 | $208M | Sell |
|
|||||
2015
Q4 | $203M | Sell |
|
|||||
2015
Q3 | $236M | Sell |
|
|||||
2015
Q2 | $266M | Sell |
|
|||||
2015
Q1 | $293M | Sell |
|
|||||
2014
Q4 | $303M | Sell |
|
|||||
2014
Q3 | $291M | Sell |
|
|||||
2014
Q2 | $305M | Buy |
|
|||||
2014
Q1 | $289M | Buy |
|
|||||
2013
Q4 | $279M | Buy |
|
|||||
2013
Q3 | $250M | Sell |
|
|||||
2013
Q2 | $280M | Buy |
|